PAYS · Paysign, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Active patient affordability programs | 135 | Q1 2026 | — |
| Adjusted EBITDA non-GAAP | $10.59M | Q1 2026 | — |
|
|
|||
| Average monthly revenue per center | $6,671 | Q1 2026 | — |
|
|
|||
| Diluted Adjusted EBITDA per share non-GAAP | $0.17 | Q1 2026 | — |
|
|
|||
| Gross dollar load volume | 26.4% | Q1 2026 | — |
|
|
|||
| Gross spend volume | 26.7% | Q1 2026 | — |
|
|
|||
| Net patient affordability programs added | 45 | Q1 2026 | — |
| Net plasma centers added | 89 | Q1 2026 | — |
| Plasma centers | 573 | Q1 2026 | — |
| EBITDA non-GAAP | $15.68M | full-year 2025 | — |
| Net patient affordability programs | 55 | full-year 2025 | — |
| Net plasma center count | 115 | full-year 2025 | — |
| Patient affordability claim volume | 79% | full-year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Software - Infrastructure — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PAYS
this stock
Paysign, Inc.
|
$509.86M | +77.1% | +48.0% | 53.7 | 2.8% |
|
MSFT
Microsoft Corp
|
$2.92T | -18.5% | +6.9% | 23.4 | 1.2% |
|
ORCL
Oracle Corp
|
$345.54B | -38.3% | +17.3% | 20.6 | 1.7% |
|
PLTR
Palantir Technologies Inc.
|
$296.14B | -30.5% | +16.7% | 138.8 | 3.2% |
|
PANW
Palo Alto Networks Inc
|
$259.98B | +73.2% | +29.0% | 261.5 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PAYS | +2.7% | +11.6% | +119.2% | +11.4% | +77.1% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +3.7% | +11.7% | +111.8% | +12.2% | +68.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.